First-line chemotherapy for non-small-cell lung cancer: Is there a superior regimen based on histology?

被引：44
作者：
Einhorn, Lawrence H. [1 ]
机构：
[1] Indiana Univ, Dept Med, Div Hematol Oncol, Indianapolis, IN 46204 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 21期
关键词：
D O I：
10.1200/JCO.2008.17.2056
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3485 / 3486
页数：2
相关论文
共 20 条
[1]  
[Anonymous], P AM SOC CLIN ONCOL
[2]   Twenty-two years of phase III trials for patients with advanced non-small-cell lung cancer: Sobering results [J].
Breathnach, OS ;
Freidlin, B ;
Conley, B ;
Green, MR ;
Johnson, DH ;
Gandara, DR ;
O'Connell, M ;
Shepherd, FA ;
Johnson, BE .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (06) :1734-1742
[3]  
Einhorn LH, 2006, J THORAC ONCOL, V1, P737
[4]   Cellular and pharmacogenetics foundation of synergistic interaction of pemetrexed and gemcitabine in human non-small-cell lung cancer cells [J].
Giovannetti, E ;
Mey, V ;
Nannizzi, S ;
Pasqualetti, G ;
Marini, L ;
Del Tacca, M ;
Danesi, R .
MOLECULAR PHARMACOLOGY, 2005, 68 (01) :110-118
[5]   Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy [J].
Hanna, N ;
Shepherd, FA ;
Fossella, FV ;
Pereira, JR ;
De Marinis, F ;
von Pawel, J ;
Gatzemeier, U ;
Tsao, TCY ;
Pless, M ;
Muller, T ;
Lim, HL ;
Desch, C ;
Szondy, K ;
Gervais, R ;
Shaharyar ;
Manegold, C ;
Paul, S ;
Paoletti, P ;
Einhorn, L ;
Bunn, PA .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (09) :1589-1597
[6]   RETRACTED: Pharmacogenomic strategies provide a rational approach to the treatment of cisplatin-resistant patients with advanced cancer (Retracted article. See vol. 28, pg. 5229, 2010) [J].
Hsu, David S. ;
Balakumaran, Bala S. ;
Acharya, Chaitanya R. ;
Vlahovic, Vanja ;
Walters, Kelli S. ;
Garman, Katherine ;
Anders, Carey ;
Riedel, Richard F. ;
Lancaster, Johnathan ;
Harpole, David ;
Dressman, Holly K. ;
Nevins, Joseph R. ;
Febbo, Phillip G. ;
Potti, Anil .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (28) :4350-4357
[7]  
Pignon JP, 2006, J CLIN ONCOL, V24, p366S
[8]   RETRACTED: A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer (Retracted Article. See vol 356, pg 201, 2007) [J].
Potti, Anil ;
Mukherjee, Sayan ;
Petersen, Rebecca ;
Dressman, Holly K. ;
Bild, Andrea ;
Koontz, Jason ;
Kratzke, Robert ;
Watson, Mark A. ;
Kelley, Michael ;
Ginsburg, Geoffrey S. ;
West, Mike ;
Harpole, David H., Jr. ;
Nevins, Joseph R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (06) :570-580
[9]   A RANDOMIZED TRIAL OF THE 4 MOST ACTIVE REGIMENS FOR METASTATIC NON SMALL-CELL LUNG-CANCER [J].
RUCKDESCHEL, JC ;
FINKELSTEIN, DM ;
ETTINGER, DS ;
CREECH, RH ;
MASON, BA ;
JOSS, RA ;
VOGL, S .
JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (01) :14-22
[10]   Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer [J].
Sandler, AB ;
Nemunaitis, J ;
Denham, C ;
von Pawel, J ;
Cormier, Y ;
Gatzemeier, U ;
Mattson, K ;
Manegold, C ;
Palmer, MC ;
Gregor, A ;
Nguyen, B ;
Niyikiza, C ;
Einhorn, LH .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (01) :122-130
12